Arcutis Biotherapeutics Inc (ARQT)
14.99
+0.88
(+6.24%)
USD |
NASDAQ |
Dec 20, 16:00
15.01
+0.02
(+0.13%)
After-Hours: 20:00
Arcutis Biotherapeutics Profit Margin (Quarterly): -92.81% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Mirum Pharmaceuticals Inc | -15.75% |
| Biogen Inc | 15.76% |
| Vertex Pharmaceuticals Inc | 37.71% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -139.0% |
| Return on Assets | -49.01% |
| Return on Invested Capital | -56.93% |
| Gross Profit Margin (Quarterly) | 87.70% |
| Operating Margin (Quarterly) | -87.29% |
| Return on Net Operating Assets | -281.8% |